281 results about "Proteolysis" patented technology

Present invention teaches the method of using a keratin hydrolysis peptide (“KHP”) solution to promote the growth of soybean plants under flood stress. By selectively choosing specific weights of feathers and water, and treating the mixture to a high-temperature high-pressure hydrolysis process, the resulting solution is confirmed to contain at least 253 peptides and then apply to the soil containing the soybean at a specific growth stage after germination. Optionally, the KHP solution can be diluted by water as disclosed in the application.

The invention provides a preparation method, application and composition of oat polypeptide, and relates to the technical field of cosmetics. The preparation method disclosed by the invention comprises the following steps: (1) moistening and swelling oat, drying after steam explosion treatment, and adding pectinase, cellulase and amylase to carry out carbohydrate enzymolysis, so as to obtain oat residues after enzymolysis; (2) adding compound protease into the oat residues subjected to enzymolysis, and carrying out primary proteolysis under the condition that the addition amount of ethanol with the volume concentration of 3-8%, so as to obtain enzymolysis slurry A; the compound protease comprises papain, bromelain and flavourzyme in a mass ratio of (3-6): (3-6): 2; (3) adding trypsin into the enzymolysis serous fluid A to carry out secondary proteolysis to obtain enzymolysis serous fluid B; and (4) carrying out ultrafiltration on the enzymolysis slurry B to obtain the oat polypeptide. The obtained oat polypeptide is small in molecular weight and high in content, is used for preparing cosmetics, and has remarkable effects of preserving moisture, resisting wrinkles and reducing skin roughness.

The invention discloses extraction of polydeoxyribonucleotide as well as preparation and application of a PDRN-Ce (Polydeoxyribonucleotide-Ce) microsphere cluster. The extraction and purification method comprises the following steps: mixing in-vitro fish testis tissues with water, carrying out crushing treatment and homogenization treatment on an obtained premix, carrying out proteolysis and solid-liquid separation, and collecting supernate to obtain enzymatic hydrolysate; wherein protease used for proteolysis comprises neutral protease; carrying out alcohol precipitation on the enzymatic hydrolysate by adopting an alcohol solvent, and collecting a precipitate; and dissolving the precipitate in water, desalting and drying. According to the extraction method, the purity and the yield of the poly-deoxyribonucleotide are remarkably improved, the preparation method is low in cost and convenient to operate, the prepared poly-deoxyribonucleotide is stable in property, small in molecular weight and easy to absorb by skin, in order to further improve the bioavailability of the extracted poly-deoxyribonucleotide, the PDRN-Ce microsphere cluster is prepared, and the PDRN-Ce microsphere cluster can be used for preparing the poly-deoxyribonucleotide. Good application prospects are realized.

The present invention relates to compounds of formula (I) useful for the ex vivo, in vitro or in vivo degradation of BRAF by the ubiquitin proteolysis pathway. The invention also provides pharmaceutically acceptable compositions comprising the compounds, and methods of using the compositions in the treatment of various diseases, disorders, and / or conditions.

The invention belongs to the technical field of bioengineering and application thereof, and particularly relates to a laver compound zymolyte as well as a preparation method and application thereof. The compound enzyme is prepared through a compound enzymolysis process of protease and laver polysaccharide enzyme. Compared with a traditional single proteolysis process, a composite enzymolysis process of adding the high-enzyme-activity laver polysaccharide enzyme effectively breaks a'polysaccharide-protein 'composite structure of laver cell walls, so that the viscosity of zymolyte is reduced, high laver liquefaction rate and high product yield are realized, and the release efficiency of nutritional active ingredients is remarkably improved; the product is rich in low-molecular-weight polypeptide and oligomeric porphyra polysaccharide. The obtained zymolyte shows the comprehensive effects of improving joint activity, inhibiting osteophyte formation, adjusting cartilage metabolism balance and relieving inflammatory response in an osteoarthritis mouse model, and osteoarthritis is effectively relieved. According to the invention, efficient release and utilization of nutritional active ingredients of the laver are realized, and powerful technical support is provided for developing high-valued products, such as health-care products and functional foods, which have the function of maintaining joint health.

The present disclosure relates to bifunctional compounds, which find utility as modulators of Protein Arginine N-Methyl Transferase 5 (PRMT5) in MTAP deleted / low expressing cells. In particular, the present disclosure is directed to bifunctional compounds, which contain on one end a ligand which binds to an E3 ubiquitin ligase and on the other end a moiety which binds the PRMT5-MTA complex, such that the PRMT5 protein is placed in proximity to the ubiquitin ligase to effectuate ubiquitination, and therefore, degradation (and inhibition) of PRMT5 protein, as well as methods for their preparation and use. Specifically, the present invention describes compounds of Formula (I) and pharmaceutically acceptable salts, hydrates and solvates, as well as methods for their preparation and use

The present disclosure relates to enzymes, compositions and methods for performing conditional homologous recombination of a targeted DNA molecule or genome by using modified proteins comprising nucleic acid DNA binding proteins with protease-conditional recombinase (hereinafter “ProRec”) activity. Namely a new cre recombinase pro enzyme, compositions / kit and sensors comprising the cre recombinase pro enzyme of the present disclosure. Namely, a cre recombinase pro-enzyme, for identifying and quantifying proteolytic activity in a disease or an infection, comprising intein mediated circularization, a flip-excision cassette comprising an output reporter and / or effector protein; a linker sequence cleavable by a protease.

Provided herein are compounds of formula (I), or their tautomers, stereoisomers, or pharmaceutically acceptable salts. These compounds are useful as KRAS(G12D) proteolytic agents and / or inhibitors. [Case 1] TIFF2026511222000314.tif64165

The invention discloses a method for synergistically improving the bleeding problem in the storage process of pea starch-quinoa protein gel through proteolysis and gellan gum addition. The invention provides a method for preparing gel. The method comprises the following steps: (1) mixing enzymolysis quinoa protein, pea starch, gellan gum and water to obtain a mixed suspension; and (2) heating and gelatinizing the mixed suspension, and cooling and molding to obtain the gel. The gel prepared by the method has the beneficial effects that the water binding capacity is high, and the bleeding rate is low; microscopic structure observation shows that a highly compact and uniform network is formed, and no obvious bubbles exist; low-field nuclear magnetic resonance analysis shows that the bound water proportion is obviously increased; a dynamic rheological test proves that the gel has excellent gel stability; and the process is simple and safe and easy for industrial production. The invention provides a reliable technical scheme for the development of high-protein nutritional soft food for old people.

The microorganism strain Pediococcus acidilactici TAK 589 CoccobEst is a new antimicrobial and antioxidant probiotic, CoccobEst inhibits the growth of the enteropathogens L. monocytogenes, E. coli, S. enteritidis, S. typhimurium, S. sonnei, S. aureus, E. faecalis and C. sakazakii, but does not inhibit lactobacilli of natural intestinal microbiota. The strain's antimicrobial properties are enhanced by periplasmic peptidoglycan hydrolases with proteolytic activity. CoccobEst is used as a zootechnieai feed additive to prevent bacterial infections in the gastrointestinal tract of farm animals and pets and to prevent and reduce diarrhea. CoccobEst has highly active antioxidant defense system, increasing the redox activity of glutathione and reducing oxidative stress in cells. Therefore, CoccobEst is used as a food supplement or functional food for humans to prevent bacterial infections of the gastrointestinal tract and to prevent and reduce oxidative stress. In addition, CoccobEst is used as a starter culture in fermentation of vegetables.

The invention discloses a method for preparing a soybean protein hydrolysate-soybean seed coat polysaccharide compound based on ultrasonic treatment.The method belongs to the technical field of food processing and manufacturing, soybean protein isolate hydrolysate with a balanced structure is obtained by controlling enzymolysis conditions, then the soybean protein isolate hydrolysate is compounded with soybean seed coat polysaccharide, moderate ultrasonic treatment is combined, and the soybean protein hydrolysate-soybean seed coat polysaccharide compound is obtained. Compared with the prior art, the preparation method has the advantages that the emulsifying property is improved while the protein structure functionality is maintained, and the preparation method is simple in process, green, environmentally friendly and capable of achieving large-scale production and is suitable for functional emulsion food, active substance delivery and development of other emulsion-based products.

Use of glycogen synthase kinase-3 (GSK3) as a protease, and a GSK3-based proteolysis-targeting chimera (PROTAC) and a preparation method and use thereof are provided, belonging to the technical field of proteolysis. The GSK3 and an N-terminal domain, an intermediate domain, or a C-terminal domain thereof have a protease activity and can achieve efficient proteolysis. Based on the GSK3 and other similar proteases, PROTACs can be developed to achieve efficient targeted proteolysis of a target protein.

The present disclosure can improve the degree of soy protein proteolysis and the ability to produce valine, isoleucine, and leucine, which are branched-chain amino acids, as well as other amino acids, such as threonine, glycine, tyrosine, and lysine. Accordingly, the present disclosure can prevent sarcopenia and has antioxidant activity. Also, the present disclosure can maintain protein metabolic balance and relieve sarcopenia by muscle synthesis.The self-aggregation, hydrophobicity, and intestinal adhesion of a mixed strain is improved compared to a case where a single strain used for the mixed strain is used. Therefore, when the mixed strain of the present disclosure is ingested, the strain can remain for a long time in the intestine.

The present application provides a kind of as CDK2 protein degradation agent and its use. Specifically related to the compound shown in formula (I), its tautomer, stereoisomer, hydrate, solvate, pharmaceutically acceptable salt or prodrug and preparation method thereof, and the use in the preparation for treating CDK2 related disease drug.

Disclosed are substituted heterocyclic compounds and proteolysis-targeting chimeric molecules (PROTACs). The substituted heterocycles disclosed herein are shown to be useful in inhibiting c-MYC. The disclosed PROTACs are shown to induce degradation of c-MYC protein. The substituted heterocyclic compounds and proteolysis-targeting chimeric molecules (PROTACs) disclosed, herein may be utilized as therapeutics for treating cancer and cell proliferative disorders.

A process for using bacterial or fungal metalloprotease and trypsin to solve problems associated with conventional protease extraction techniques by dramatically reducing temperature, incubation time and proteolysis during protease extraction. The present disclosure relates to a protease treatment for increasing yield from plant or other material by extracting nutrients from the fibrous waste portion of milled plant material while preserving the nutritional and functional qualities of the extracted material for use as a food product. The process preserves the quality of the extracted material, including beta glucan and protein, by utilizing low temperatures and minimal protease activity and digestion time during extraction.

The invention relates to the technical field of proteolysis, in particular to a microwave-assisted proteolysis device which comprises a sample tray arranged on the inner side of a box body, and the sample tray comprises an upper tray arranged on the inner side of the box body and a lower tray fixed to the bottom of the upper tray. A positioning assembly for synchronously clamping the plurality of enzymolysis tanks and keeping the enzymolysis tanks stable is arranged on the sample tray, and the positioning assembly comprises a plurality of first annular discs arranged on the upper tray and a plurality of second annular discs arranged on the lower tray. The stability of each enzymolysis tank during enzymolysis is ensured, non-uniform microwave heating caused by lateral inclination of the enzymolysis tanks is avoided, the reaction consistency in the enzymolysis process is improved, the proteolysis effect is enhanced, meanwhile, the stable digestion tank position can ensure that each sample reacts under the same condition, and the enzymolysis accuracy is improved. The experimental error caused by non-uniform heating of the sample is reduced, the reliability and the accuracy of the experimental result are improved, and the application range of the enzymolysis device is expanded.

The invention relates to the field of biological fermentation, in particular to a method for efficiently preparing anti-aging ergothioneine through fermentation of compound bacteria combined with bolete and application thereof.The method comprises the steps that halophilic bacillus SC-1, halophilic archaea IR-2 and thermophilic casein dissolving bacteria PC-3 are mixed according to the volume ratio of 1: 1: 1, bolete and pleurotus citrinopileatus are used as raw materials, and a mixture is prepared through fermentation; fermenting for 120 hours in an optimized basic culture medium under the conditions that the temperature is 30 + / -0.5 DEG C, the speed is 150rpm + / -10rpm and the pH value is 5.8 + / -0.2; through a step-by-step process of purifying EGT by using D101 resin and purifying RNET-1 by using DEAE-52 resin, a double-active-component extract is synchronously obtained. Through the synergistic effect of three strains with complementary functions, an efficient system of raw material degradation, carbon source supply, double precursor synthesis and double active component accumulation is constructed, synchronous high yield of ergothioneine and novel antioxidant protein RNET-1 is realized for the first time, and the blank of single active component in the prior art is filled.

The invention discloses selenium-containing chickpea peptide, a preparation method thereof and application of the selenium-containing chickpea peptide in preparation of antihypertensive drugs, and belongs to the technical field of bioactive peptides. According to the method, selenium-rich bacillus natto is used for fermenting chickpeas to obtain selenium-containing chickpea protein hydrolysate, and then the selenium-containing chickpea peptides PQM and PQML are obtained through fermentation condition optimization and a quantitative peptidomics technology. Experiments prove that the selenium-containing chickpea peptide has good in-vivo stability, bioavailability and antihypertensive activity, has the effect of inhibiting the activity of angiotensin converting enzyme (ACE), and has the potential of preventing or treating hypertension.

The invention discloses a multifunctional special dietary food skin beautifying and shaping formula and application, and belongs to the technical field of beauty treatment. The multifunctional special dietary food at least comprises collagen peptide, collagen tripeptide, skipjack elastin peptide, carob bean extract, phosphatidylserine, casein hydrolytic peptide, nicotinamide, rice bran oil powder, haematococcus pluvialis, cranberry powder, oriental cherry flower powder, pig blood peptide powder, red date peptide powder and cattle spleen peptide. The health-care product can comprehensively supplement nutrition recovered after exercise, has the effects of beautifying, shaping and removing wrinkles, can effectively relieve pressure and regulate emotion, and also has the effects of improving female physiological health, strengthening the spleen and stomach and enhancing immunity.

The application discloses a controllable preparation method of high-activity earthworm protein peptide and belongs to the technical field of earthworm processing. The preparation method comprises the following steps: (1) adding amylase and cutinase to earthworm paste for hydrolysis; (2) filtering by using a filter; (3) hydrolyzing the filtrate by using a composite enzyme; (4) adding alkaline protease to the filter residue for hydrolysis, and then adding high-temperature protease for hydrolysis; (5) filtering the hydrolyzed paste, and then filtering and treating the paste by using a ceramic microfilter to obtain low-molecular-weight earthworm protein peptide; and (6) mixing the obtained earthworm water-soluble protein hydrolysate and the obtained earthworm insoluble protein polypeptide, and then concentrating and drying to obtain high-activity earthworm protein peptide. According to the application, the water-soluble protein and the water-insoluble protein in the earthworm are step-by-step differentially hydrolyzed, the protein resources in the earthworm are maximally utilized, the polypeptide / protein yield can be more than 85%, waste is avoided, and the activity of the obtained protein peptide is ensured.

Provided herein are cytokines or functional fragments thereof that, in some embodiments, are engineered to be masked by a masking moiety at one or more receptor binding site(s) of the cytokine or functional fragment thereof. In some embodiments, the cytokines are engineered to be activatable by a protease at a target site, such as in a tumor microenvironment, by including a proteolytically cleavable linker. In some embodiments, the proteolytically cleavable linker links the cytokine to the masking moiety, links the cytokine to a half-life extension domain, and / or links the masking moiety to a half-life extension domain. The masking moiety blocks, occludes, inhibits (e.g., decreases) or otherwise prevents (e.g., masks) the activity or binding of the cytokine to its cognate receptor or protein. Upon proteolytic cleavage of the cleavable linker at the target site, the cytokine becomes activated, which renders it capable of binding to its cognate receptor or protein with increased affinity.

The invention belongs to the technical field of action target screening and identification, and particularly relates to a method for screening and identifying a Nav channel protein binding agent based on ligand-induced protein stability change. The method comprises the following steps: firstly, carrying out mild lysis on cells of high-expression voltage-gated sodium ion channel protein (Nav channel protein) to obtain lysate containing active Nav channel protein, carrying out contrast incubation on the lysate, a compound to be detected and a solvent, carrying out restrictive enzymolysis by using protease in the presence of a surfactant, and carrying out freeze-drying to obtain the high-expression voltage-gated sodium ion channel protein (Nav channel protein). Representing the retention amount of the target protein and the internal reference protein, and evaluating the protective capability of the compound to be detected on degradation of the target protein to judge the affinity. The method has the advantages of high identification speed, economy and high efficiency, overcomes the problems that the existing Nav channel protein binding agent screening method is tedious, high in technical difficulty and depends on special large instruments, and can be used for screening action targets without specially constructing cells and purifying proteins by large instruments, so that the screening efficiency is effectively improved, and the screening cost is effectively reduced.

The invention discloses a novel brain protein enzymolysis active peptide for improving concentration and application thereof. Belongs to the technical field of new active peptide preparation. According to the invention, fresh pig brain is used as a raw material for enzymolysis and purification to successfully prepare the novel active peptide PAVP through brain protein enzymolysis. Efficacy verification is further carried out on the oligopeptide PAVP, and experimental results show that the oligopeptide PAVP can remarkably prolong the time of exploration of mice on new things in a new things recognition experiment and improve the concentration degree; in order to further verify the action mechanism of the PAVP, the expression quantities of synaptic plasticity markers PSD-95, BDNF and p-CREB in a mouse body are detected on the molecular level, and experimental results show that the PAVP not only repairs the synaptic touchable injury, but also possibly further enhances the synaptic function so as to achieve the purpose of improving the concentration degree.

The invention relates to the technical field of food processing, in particular to an alkali-induced glycosylated tilapia protein hydrolysate loaded with fat-soluble polyphenol as well as a preparation method and application of the alkali-induced glycosylated tilapia protein hydrolysate. The glycosylated tilapia mossambica protein hydrolysate is prepared by adopting flavourzyme with mild action conditions for moderate hydrolysis and combining with a green, efficient and reaction degree-adjustable alkali-induced propylene glycol alginate (PGA) glycosylation strategy, so that the water solubility and emulsibility of tilapia mossambica protein are effectively improved, and the tilapia mossambica protein hydrolysate can be used for preparing the tilapia mossambica protein hydrolysate. The glycosylated protein hydrolysate (modified tilapia protein) is used as a carrier to develop an oral delivery system of fat-soluble polyphenols such as quercetin and the like, so that the bioaccessibility of the fat-soluble polyphenols is improved, and the fat-soluble polyphenols can be developed into functional food ingredients to improve the health condition of special groups; the high-value utilization of the tilapia protein in the protein-based polyphenol functional food ingredients is promoted.

The present application relates to a compositions and methods comprising or expressing a hevamine A-related MoMo30 protein from Momordica balsamina. The MoMo30 protein is about 30 kDa in size, is stable after being autoclaved at 120° C. for 30 min, resists proteolytic cleavage by trypsin, exhibits mannose-sensitive binding to HIV gp120, exhibits hemagglutinin and chitinase activity, is capable of activating and stimulating T cell proliferation, is capable of preventing infection by HIV-1 or alleviating symptoms in an HIV-1 infected patients, and comprises an amino acid sequence of SEQ ID NO: 4. The MoMo30 protein and / or a nucleic acid encoding the same may be used in methods for preventing or treating microbial infections by HIV, SARS-CoV-2 and other enveloped viruses, as well as other microorganisms comprising cell surface proteins containing glycan residues, such as mannose.

The application discloses selenium-containing chickpea peptides, a preparation method thereof and application of the selenium-containing chickpea peptides in preparation of blood pressure lowering drugs, and belongs to the technical field of bioactive peptides. Selenium-enriched Bacillus natto is used to ferment chickpeas to obtain selenium-containing chickpea protein hydrolysate, and then fermentation conditions are optimized and quantitative peptidomics technology is used to obtain selenium-containing chickpea peptides PQM and PQML. Experiments prove that the selenium-containing chickpea peptides have good in-vivo stability, bioavailability and blood pressure lowering activity, have an effect of inhibiting angiotensin converting enzyme (ACE) activity, and have potential for preventing or treating hypertension.

The invention provides an ultrasonic response type microsphere preparation entrapped with a protein degradation agent as well as a preparation method and application of the ultrasonic response type microsphere preparation. The microsphere is of a microsphere structure entrapped with a protein degradation agent and formed by a conjugate of a biodegradable polymer and a sound-sensitive agent and the protein degradation agent. According to the invention, the targeted protein degradation agent is entrapped in a biodegradable novel polymer matrix, so that the slow release effect of the medicine is realized, and the long-acting effect is achieved at a specific part in the body. The microsphere combines the respective advantages of an ultrasonic technology and a targeted protein degradation technology, and the two technologies work together, so that the controllability of drug release is remarkably improved, a synergistic effect is achieved, and the treatment effect is improved.

The invention discloses a method for enriching and extracting soluble protein in a tissue sample, which comprises the following steps: adding the tissue sample into a low-salt buffer solution, homogenizing, centrifuging, collecting supernatant precipitate, resuspending the precipitate by using Triton, and obtaining the supernatant to obtain an extracting solution; adding anhydrous acetonitrile to precipitate protein and collecting precipitate; carrying out proteolysis reductive alkylation and quenching reaction treatment on the precipitate to obtain a peptide fragment sample; desalting by using a peptide fragment sample desalting cleaning solution; after washing, adding a desalted eluent for eluting, collecting an eluent containing the peptide fragment, and drying to obtain a desalted peptide fragment; performing reversed-phase fractionation chromatography under an alkaline condition; and finally, LC-MS / MS detection is carried out. Under the condition that a strong denaturing agent is not introduced, secretory protein, cytoplasm protein and membrane protein can be selectively enriched, meanwhile, most of cell nucleus protein and tissue interstitial fibrin are effectively removed, and therefore the detection capacity of follow-up mass spectrometric detection on extremely-low-abundance circulating markers is remarkably improved.

The present invention relates to enhancement and stabilization of proteolytic activity of proteases. The present invention discloses a method for enhancing and / or stabilizing the proteolytic activity of a protease, characterized in that said method comprises (i) contacting the protease with a reducing agent wherein the cysteine residues of the protease are maintained in the reduced state, (ii) removing substantially all of the oxygen from the area surrounding the protease, and (ii) removing the cysteine residues of the protease from the reducing agent. And (iii) binding the protease to an anionic polymer matrix such that the protease is non-covalently bound to the anionic polymer matrix.